Locate Fort Smith buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
Dr. Juan Martin Hughes, M.D.
1301 South Waldron Road
Suite B
Fort Smith, AR 72903
Main Tel: (479) 595-2437
|
Dr. Gina Ferrari, M.D.
3700 Cliff Drive
Fort Smith, AR 72903
Main Tel: (479) 484-5600
|
Mohammed S. Ur Rehman, M.D.
8909 Lakeside Way
Fort Smith, AR 72903
Main Tel: (479) 471-4600
|
Kristi Marie Kindrick, M.D.
10301 Mayo Drive
Barling, AR 72923
Main Tel: (479) 494-5700
|
Dr. Cynthia Almond, M.D.
100 Woodland Hills Blvd
Roland, OK 74954
Main Tel: (918) 427-3760
|
Kalyan Chowdary Akkineni, M.D.
5808 Callaway Lane
Fort Smith, AR 72916
Main Tel: (479) 471-4600
|
Fort Smith Medical Group
1618 North A Street
Fort Smith, AR 72901
Main Tel: (479) 321-3645
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.